BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9490291)

  • 1. Human gene mutations. Gene symbol: HFE. Disease: hereditary haemochromatosis.
    de Villiers JN; Scholtz CL; Hoogendijk CF; Cawood EJ; Kotze MJ
    Hum Genet; 1998 Jan; 102(1):127. PubMed ID: 9490291
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary haemochromatosis mutations (HFE) in patients with Type II diabetes mellitus.
    Braun J; Donner H; Plock K; Rau H; Usadel KH; Badenhoop K
    Diabetologia; 1998 Aug; 41(8):983-4. PubMed ID: 9726605
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemochromatosis, HFE and genetic complexity.
    Risch N
    Nat Genet; 1997 Dec; 17(4):375-6. PubMed ID: 9398831
    [No Abstract]   [Full Text] [Related]  

  • 4. Two novel polymorphisms (E277K and V212V) in the haemochromatosis gene HFE.
    Bradbury R; Fagan E; Payne SJ
    Hum Mutat; 2000 Jan; 15(1):120. PubMed ID: 10612845
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemochromatosis... definite maybe!
    Nat Genet; 1996 Aug; 13(4):375-6. PubMed ID: 8696321
    [No Abstract]   [Full Text] [Related]  

  • 6. Iron, HFE, and hemochromatosis update.
    Cuthbert JA
    J Investig Med; 1997 Dec; 45(9):518-29. PubMed ID: 9444878
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. The European Haemochromatosis Consortium.
    Merryweather-Clarke AT; Pointon JJ; Shearman JD; Robson KJ; Jouanolle AM; Mosser A; David V; Le Gall JY; Halsall DJ; Elsey TS; Kelly A; Cox TM; Clare M; Bomford A; Vandwalle JL; Rochette J; Borot N; Coppin H; Roth MP; Ryan E; Crowe J; Totaro A; Gasparini P; Roetto A; Walker AP
    Nat Genet; 1999 Nov; 23(3):271. PubMed ID: 10545942
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hereditary hemochromatosis associated with hypoceruloplasminemia with absence of mutations in the HFE gene]].
    Del Rey R; Froilán C; Comas C; Villanueva R; Olveira A
    Rev Esp Enferm Dig; 2000 Sep; 92(9):610-1. PubMed ID: 11138244
    [No Abstract]   [Full Text] [Related]  

  • 9. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis.
    Jeffrey GP; Chakrabarti S; Hegele RA; Adams PC
    Nat Genet; 1999 Aug; 22(4):325-6. PubMed ID: 10431233
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical usefulness of the detection of mutations of the HFE gene in hemochromatosis].
    Oliva R; Sánchez M; Bruguera M; Rodés J
    Gastroenterol Hepatol; 2000 Nov; 23(9):433-5. PubMed ID: 11126040
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical haemochromatosis in HFE mutation carriers.
    Poullis A; Moodie SJ; Maxwell JD
    Lancet; 2002 Aug; 360(9330):411-2; author reply 413-4. PubMed ID: 12241803
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations.
    Beutler E
    Lancet; 1997 Feb; 349(9048):296-7. PubMed ID: 9024367
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemochromatosis and HLA-H.
    Jouanolle AM; Gandon G; Jézéquel P; Blayau M; Campion ML; Yaouanq J; Mosser J; Fergelot P; Chauvel B; Bouric P; Carn G; Andrieux N; Gicquel I; Le Gall JY; David V
    Nat Genet; 1996 Nov; 14(3):251-2. PubMed ID: 8896550
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemochromatosis with HFE gene mutation in a Japanese patient.
    Sohda T; Okubo R; Kamimura S; Ohkawara T
    Am J Gastroenterol; 2001 Aug; 96(8):2487-8. PubMed ID: 11513196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemochromatosis and HLA-H.
    Jazwinska EC; Cullen LM; Busfield F; Pyper WR; Webb SI; Powell LW; Morris CP; Walsh TP
    Nat Genet; 1996 Nov; 14(3):249-51. PubMed ID: 8896549
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemochromatosis: diagnosis and management after the cloning of the HFE gene.
    Powell LW; Bassett ML
    Aust N Z J Med; 1998 Apr; 28(2):159-63. PubMed ID: 9612522
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Noll WW; Belloni DR; Stenzel TT; Grody WW
    Nat Genet; 1999 Nov; 23(3):271-2. PubMed ID: 10610176
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM.
    Dubois-Laforgue D; Caillat-Zucman S; Djilali-Saiah I; Larger E; Mercadier A; Boitard C; Bach JF; Timsit J
    Diabetes Care; 1998 Aug; 21(8):1371-2. PubMed ID: 9702455
    [No Abstract]   [Full Text] [Related]  

  • 19. Putting a hold on 'HLA-H'.
    Mercier B; Mura C; Ferec C
    Nat Genet; 1997 Mar; 15(3):234. PubMed ID: 9054932
    [No Abstract]   [Full Text] [Related]  

  • 20. Celtic origin of the C282Y mutation of hemochromatosis.
    Lucotte G
    Blood Cells Mol Dis; 1998 Dec; 24(4):433-8. PubMed ID: 9851897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.